JP2000511907A - 紫外線誘発皮膚光損傷及び癌に対する予防剤としてのゲニステイン - Google Patents
紫外線誘発皮膚光損傷及び癌に対する予防剤としてのゲニステインInfo
- Publication number
- JP2000511907A JP2000511907A JP10500949A JP50094998A JP2000511907A JP 2000511907 A JP2000511907 A JP 2000511907A JP 10500949 A JP10500949 A JP 10500949A JP 50094998 A JP50094998 A JP 50094998A JP 2000511907 A JP2000511907 A JP 2000511907A
- Authority
- JP
- Japan
- Prior art keywords
- genistein
- skin
- uvr
- induced
- μmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.ヒト皮膚へのUVR曝露の有害作用を抑制する方法であって、ゲニステイン の治療的有効量をUVR曝露の時間に充分に近接する時間で皮膚に局所適用して 、皮膚のUVR−誘発損傷を抑制する方法。 2.曝露に先だってゲニステインを皮膚に適用する請求項1に記載の方法。 3.曝露の前2時間以内にゲニステインを皮膚に適用する請求項2に記載の方法 。 4.曝露の2時間以内にゲニステインを適用する請求項1に記載の方法。 5.少なくとも0.1μmol/cm2皮膚の量でゲニステインを適用する請求項 1に記載の方法。 6.ゲニステインが0.1〜1.0μmol/cm2の濃度で、担体と混合されて いる請求項1に記載の方法。 7.ゲニステインが0.1〜1.0μmol/cm2の濃度で、化粧品又は医薬品 の性質を有する組成物と混合されている請求項1に記載の方法。 8.ゲニステインが以下の少なくとも1種と混合される請求項1に記載の方法。 ジメチルスルホキシド;ジメチルスルホキシド:アセトン;ツイーン80;ツ イーン80:水;パラアミノ 安息香酸;ベンゾフェノン誘導体;二酸化チタン、酸化亜鉛;ビタミンA、C及 びEを含む抗酸化ビタミン類;化粧用モイスチャークリーム、スキンケアローシ ョン;スクアレン;アロエベラ;日焼け止めクリーム;脂質;α−ヒドロキシ酸 ;レチン−A;β−カロチン 9.UVRの癌誘発作用を緩和する請求項1に記載の方法であって、ゲニステイ ンのUVR−誘発皮膚光発癌を抑制する充分量を局所適用することを特徴とする 方法。 10.UVRの皮膚光老化作用を抑制する請求項1に記載の方法であって、ゲニ ステインのUVR−誘発老化を抑制する充分量を局所適用することを特徴とする 方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/657,915 US5824702A (en) | 1996-06-07 | 1996-06-07 | Genistein as a preventive against ultraviolet induced skin photodamage and cancer |
US08/657,915 | 1996-06-07 | ||
PCT/US1997/011963 WO1997046208A2 (en) | 1996-06-07 | 1997-06-09 | Genistein as a preventive against ultraviolet induced skin photodamage and cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2000511907A true JP2000511907A (ja) | 2000-09-12 |
JP2000511907A5 JP2000511907A5 (ja) | 2005-03-10 |
Family
ID=24639167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10500949A Pending JP2000511907A (ja) | 1996-06-07 | 1997-06-09 | 紫外線誘発皮膚光損傷及び癌に対する予防剤としてのゲニステイン |
Country Status (11)
Country | Link |
---|---|
US (1) | US5824702A (ja) |
EP (1) | EP0918504B1 (ja) |
JP (1) | JP2000511907A (ja) |
AT (1) | ATE234599T1 (ja) |
AU (1) | AU716131B2 (ja) |
CA (1) | CA2257579C (ja) |
DE (1) | DE69719994T2 (ja) |
DK (1) | DK0918504T3 (ja) |
ES (1) | ES2188963T3 (ja) |
PT (1) | PT918504E (ja) |
WO (1) | WO1997046208A2 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003002819A (ja) * | 2001-06-22 | 2003-01-08 | Naris Cosmetics Co Ltd | 皮膚組成物 |
JP2003002820A (ja) * | 2001-06-22 | 2003-01-08 | Naris Cosmetics Co Ltd | 皮膚組成物 |
JP2004504276A (ja) * | 2000-06-26 | 2004-02-12 | ザ、リージェンツ、オブ、ザ、ユニバーシティ、オブ、ミシガン | ヒトの皮膚の光老化を防止するためのegf−rタンパク質チロシンキナーゼ抑制剤の使用 |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPN166195A0 (en) | 1995-03-13 | 1995-04-06 | Norvet Research Pty Limited | Process for glucan extraction |
US20050058709A1 (en) * | 1997-06-04 | 2005-03-17 | Fisher Gary J. | Methods for inhibiting photoaging of human skin using orally-administered agent |
TWI234467B (en) * | 1997-06-04 | 2005-06-21 | Univ Michigan | Composition for inhibiting photoaging of skin |
US6060070A (en) * | 1997-06-11 | 2000-05-09 | Gorbach; Sherwood L. | Isoflavonoids for treatment and prevention of aging skin and wrinkles |
US8039026B1 (en) | 1997-07-28 | 2011-10-18 | Johnson & Johnson Consumer Companies, Inc | Methods for treating skin pigmentation |
AUPP112497A0 (en) * | 1997-12-24 | 1998-01-22 | Novogen Research Pty Ltd | Compositions and method for protecting skin from UV induced immunosupression and skin damage |
US6051602A (en) * | 1998-03-16 | 2000-04-18 | The Procter & Gamble Company | Methods for regulating skin appearance |
US6683069B1 (en) | 1998-04-02 | 2004-01-27 | Regents Of The University Of Michigan | Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin |
TWI234455B (en) * | 1998-04-02 | 2005-06-21 | Univ Michigan | Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin |
US6750229B2 (en) | 1998-07-06 | 2004-06-15 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin pigmentation |
US8106094B2 (en) | 1998-07-06 | 2012-01-31 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating skin conditions |
US8093293B2 (en) | 1998-07-06 | 2012-01-10 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin conditions |
FR2781154B1 (fr) * | 1998-07-15 | 2001-09-07 | Lafon Labor | Composition therapeutique a base d'isoflavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques |
US20040131579A1 (en) * | 1998-09-10 | 2004-07-08 | Avon Products, Inc. | Method and compositions for reducing dermatological aging and for reducing bruising |
BR9914476B1 (pt) * | 1998-10-09 | 2010-11-30 | composição cosmética. | |
US6399107B1 (en) | 1998-12-22 | 2002-06-04 | Alcon Laboratories, Inc. | Use of inhibitors of gag synthesis for the treatment of corneal haze |
US7985404B1 (en) | 1999-07-27 | 2011-07-26 | Johnson & Johnson Consumer Companies, Inc. | Reducing hair growth, hair follicle and hair shaft size and hair pigmentation |
US7309688B2 (en) | 2000-10-27 | 2007-12-18 | Johnson & Johnson Consumer Companies | Topical anti-cancer compositions and methods of use thereof |
JP2001131052A (ja) * | 1999-11-09 | 2001-05-15 | Shinei Ferumentekku:Kk | 化粧品 |
JP2001131081A (ja) | 1999-11-09 | 2001-05-15 | Shinei Ferumentekku:Kk | スーパーオキサイド消去剤および飲料 |
WO2001095937A2 (en) * | 2000-08-08 | 2001-12-20 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Phytoestrogenic isoflavone compositions |
ATE363902T1 (de) * | 2000-06-14 | 2007-06-15 | Us Health | Isoflavonen gegen strahlungsinduzierte mortalität |
AU2001271296A1 (en) * | 2000-06-14 | 2001-12-24 | Alla Shapiro | Radioprotective agents |
FR2815861B1 (fr) * | 2000-10-26 | 2003-02-28 | Oreal | Utilisation de l'association d'au moins un carotenoide et d'au moins un isoflavonoide pour traiter les signes cutanes du vieillissement |
US8431550B2 (en) | 2000-10-27 | 2013-04-30 | Johnson & Johnson Consumer Companies, Inc. | Topical anti-cancer compositions and methods of use thereof |
FR2820974B1 (fr) * | 2001-02-21 | 2004-02-13 | Pharmascience Lab | Composition topique comprenant une solution vraie contenant un derive de chromane ou de chromene, son procede de preparation et son utilisation cosmetique et therapeutique |
EP1234572B1 (de) | 2001-02-26 | 2013-10-30 | Mibelle AG Cosmetics | Isoflavon-Aglykone enhaltende Hautbehandlungsmittel |
BR0207663A (pt) | 2001-02-27 | 2005-10-25 | Univ Michigan | Uso de inibidores de egfr naturais para prevenir os efeitos colaterais devido à terapia com retinóides, sabões e outros estìmulos que ativam o receptor do fator de crescimento epidérmico |
US7192615B2 (en) | 2001-02-28 | 2007-03-20 | J&J Consumer Companies, Inc. | Compositions containing legume products |
US6555143B2 (en) | 2001-02-28 | 2003-04-29 | Johnson & Johnson Consumer Products, Inc. | Legume products |
US20020160061A1 (en) * | 2001-02-28 | 2002-10-31 | Claude Saliou | Use of legume products for the treatment of external aggressions |
EP1321123A1 (de) * | 2001-12-20 | 2003-06-25 | Cognis France S.A. | Verwendung eines Extraktes der Pflanze Baptisia tinctoria in einer kosmetischen Zusammensetzung |
NZ537359A (en) * | 2002-06-25 | 2006-10-27 | Cosmeceutic Solutions Pty Ltd | Topical cosmetic compositions for transdermal delivery |
ATE312605T1 (de) * | 2002-06-29 | 2005-12-15 | Aquanova Ger Solubilisate Tech | Isoflavonkonzentrate sowie verfahren zu ihrer herstellung |
DE20213787U1 (de) * | 2002-09-04 | 2002-12-19 | Warner Lambert Co | Hautpflegemittel |
DE10301631A1 (de) * | 2003-01-17 | 2004-07-29 | Beiersdorf Ag | Kosmetische und dermatologische Zubereitungen mit einem Gehalt an Sojabohnenkeimextrakten in Kombination mit Vitamin C und/oder E sowie alpha-Glycosylrutin |
US7718813B2 (en) | 2003-08-15 | 2010-05-18 | Nature Pure Labs Sw, Inc. | Hydrolysis and purification of active plant compounds suitable for topical application |
EP1904053B1 (en) * | 2005-06-29 | 2011-08-17 | DSM IP Assets B.V. | Isoflavone nanoparticles and use thereof |
JP5129130B2 (ja) * | 2005-06-29 | 2013-01-23 | ディーエスエム アイピー アセッツ ビー.ブイ. | イソフラボンのナノ粒子を含む局所組成物 |
US9345649B2 (en) | 2006-12-21 | 2016-05-24 | Avon Products, Inc. | Cosmetic composition containing novel fractal particle-based gels |
FR2915381B1 (fr) * | 2007-04-27 | 2012-06-08 | Vincience | Utilisation d'un principe actif issu du soja (glycine max l) pour preparer une composition destinee a activer le cytochrome c |
FR2915378B1 (fr) * | 2007-04-27 | 2009-08-21 | Vincience Sa | Utilisation d'un principe actif issu du soja (glycine max l.) pour preparer une composition destinee a proteger les mitochondries |
FR2915384B1 (fr) * | 2007-04-27 | 2010-01-15 | Vincience | Utilisation d'un principe actif issu du soja (glycine maxl.) pour preparer une composition destinee a activer l'energie cellulaire et a proteger la peau des dommages oxydatifs. |
TWI411448B (zh) * | 2007-12-27 | 2013-10-11 | Avon Prod Inc | 適合用於化妝品之光學模糊色素組合物 |
US20120237623A1 (en) * | 2009-12-04 | 2012-09-20 | Avon Products, Inc. | Topical Compositions Containing Derris Scandens Benth and a Method of Treating Skin |
IT1401364B1 (it) * | 2010-07-09 | 2013-07-18 | Rottapharm Spa | Composizioni dermocosmetiche per protezione solare |
US9623003B1 (en) | 2013-04-04 | 2017-04-18 | Humanetics Corporation | Method of mitigating long and short term detrimental effects of exposure to medical imaging ionizing radiation by administration of genistein |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6061513A (ja) * | 1983-09-14 | 1985-04-09 | Sansho Seiyaku Kk | 化粧料 |
JPS62201882A (ja) * | 1985-11-18 | 1987-09-05 | Yamanouchi Pharmaceut Co Ltd | イソフラボン誘導体 |
JPH0784383B2 (ja) * | 1991-07-23 | 1995-09-13 | 辻本化学工業株式会社 | 抗発癌プロモーター剤 |
US5545398A (en) * | 1993-01-13 | 1996-08-13 | Perricone; Nicholos V. | Method and compositions for topical application to the skin of tocotrienol for prevention and/or treatment of skin damage |
JP2605607B2 (ja) * | 1993-12-08 | 1997-04-30 | 日本電気株式会社 | 半導体集積回路の故障解析装置 |
US5506211A (en) * | 1994-05-09 | 1996-04-09 | The Uab Research Foundation | Genistein for use in inhibiting osteroclasts |
DE4432947C2 (de) * | 1994-09-16 | 1998-04-09 | New Standard Gmbh | Mittel zur Behandlung der Haut und seine Verwendung |
-
1996
- 1996-06-07 US US08/657,915 patent/US5824702A/en not_active Expired - Lifetime
-
1997
- 1997-06-09 PT PT97934083T patent/PT918504E/pt unknown
- 1997-06-09 DK DK97934083T patent/DK0918504T3/da active
- 1997-06-09 WO PCT/US1997/011963 patent/WO1997046208A2/en active IP Right Grant
- 1997-06-09 AT AT97934083T patent/ATE234599T1/de not_active IP Right Cessation
- 1997-06-09 EP EP97934083A patent/EP0918504B1/en not_active Revoked
- 1997-06-09 JP JP10500949A patent/JP2000511907A/ja active Pending
- 1997-06-09 AU AU37225/97A patent/AU716131B2/en not_active Ceased
- 1997-06-09 ES ES97934083T patent/ES2188963T3/es not_active Expired - Lifetime
- 1997-06-09 CA CA002257579A patent/CA2257579C/en not_active Expired - Fee Related
- 1997-06-09 DE DE69719994T patent/DE69719994T2/de not_active Revoked
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004504276A (ja) * | 2000-06-26 | 2004-02-12 | ザ、リージェンツ、オブ、ザ、ユニバーシティ、オブ、ミシガン | ヒトの皮膚の光老化を防止するためのegf−rタンパク質チロシンキナーゼ抑制剤の使用 |
JP2003002819A (ja) * | 2001-06-22 | 2003-01-08 | Naris Cosmetics Co Ltd | 皮膚組成物 |
JP2003002820A (ja) * | 2001-06-22 | 2003-01-08 | Naris Cosmetics Co Ltd | 皮膚組成物 |
Also Published As
Publication number | Publication date |
---|---|
DK0918504T3 (da) | 2003-06-02 |
AU716131B2 (en) | 2000-02-17 |
WO1997046208A3 (en) | 1998-02-19 |
US5824702A (en) | 1998-10-20 |
WO1997046208A2 (en) | 1997-12-11 |
ES2188963T3 (es) | 2003-07-01 |
CA2257579C (en) | 2007-08-21 |
AU3722597A (en) | 1998-01-05 |
CA2257579A1 (en) | 1997-12-11 |
DE69719994T2 (de) | 2003-09-04 |
EP0918504B1 (en) | 2003-03-19 |
PT918504E (pt) | 2003-08-29 |
ATE234599T1 (de) | 2003-04-15 |
DE69719994D1 (de) | 2003-04-24 |
EP0918504A2 (en) | 1999-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2000511907A (ja) | 紫外線誘発皮膚光損傷及び癌に対する予防剤としてのゲニステイン | |
US6337320B1 (en) | Reparatives for ultraviolet radiation skin damage | |
US5698184A (en) | Compositions and methods for skin tanning and protection | |
EP1049451B1 (en) | Use of compounds for protecting skin from uv induced immunosuppression | |
US6316012B1 (en) | Cosmetic or pharmaceutical composition comprising, in combination, a peroxidase and an anti-singlet oxygen agent | |
US8911774B2 (en) | Topical composition for anti-aging skin treatment using dual DNA repair mechanism and method of use | |
JPH05186324A (ja) | 美白化粧料 | |
Kang et al. | Beneficial effects of dried pomegranate juice concentrated powder on ultraviolet B-induced skin photoaging in hairless mice | |
JP2004131498A (ja) | 皮膚外用剤 | |
KR101943302B1 (ko) | 엘라그산 또는 디하이드로미리세틴을 유효성분으로 함유하는 피부 외용제 및 화장료 조성물 | |
JP2002370962A (ja) | 美白用化粧料および皮膚老化防止・改善用化粧料 | |
JP2004331602A (ja) | 皮膚外用剤 | |
KR100355892B1 (ko) | 레티놀과 테트라디부틸 펜타에리스리틸히드록시히드로신나메이트를 함유하는 화장료 조성물 | |
CN113693966A (zh) | 一种创新型美白亮采祛斑霜及其制备方法 | |
KR100654060B1 (ko) | 레티놀과 카로티노이드 성분을 함유하는 화장료 조성물 | |
Tavakkol et al. | Delivery of vitamin E to the skin by a novel liquid skin cleanser: Comparison of topical versus oral supplementation | |
JPH11180854A (ja) | 皮膚外用剤 | |
EP0607642B1 (en) | Compositions for topical application to the skin for treatment and/or prevention of radiation-induced skin damage | |
JPH08337534A (ja) | メラニン生成抑制剤 | |
KR101434163B1 (ko) | 칡 지상부 추출물을 유효성분으로 함유하는 항산화, 항염증 및 미백 효능을 지닌 조성물 | |
KR20200021180A (ko) | 국화, 알로에, 서양송악 혼합 추출물을 유효성분으로 함유하는 피부 노화 또는 피부 주름 개선용 화장료 조성물 | |
JP2001509129A (ja) | 皮膚の老化過程を抑制するための化粧品組成物及び方法 | |
JPH09175988A (ja) | 光老化防止剤及び皮膚外用剤 | |
JP2000512658A (ja) | 損傷を与えたrna断片を含むサンスクリーン組成物 | |
JPH08337528A (ja) | メラニン生成抑制剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040526 |
|
A72 | Notification of change in name of applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A721 Effective date: 20040526 |
|
RD01 | Notification of change of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7426 Effective date: 20040524 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040623 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20060509 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060523 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20060815 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20061002 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061024 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070814 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20080207 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100810 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100818 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101111 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20101112 |